Engineering of SPECT/Photoacoustic Imaging/Antioxidative Stress Triple-Function Nanoprobe for Advanced Mesenchymal Stem Cell Therapy of Cerebral Ischemia
Minghua Yao,Xiaojing Shi,Changjing Zuo,Ming Ma,Lu Zhang,Hongbo Zhang,Xin Li,Guo-Yuan Yang,Yaohui Tang,Rong Wu
DOI: https://doi.org/10.1021/acsami.0c10500
2020-08-18
Abstract:The precise transplantation, long-term tracking, and maintenance of stem cells with maximizing therapeutic effect are significant challenges in stem cell-based therapy for stroke treatment. In this study, a unique core–shell labeling nanoagent was prepared by encapsulating a cobalt protoporphyrin IX (CoPP)-loaded mesoporous silica nanoparticle (CPMSN) into a <sup>125</sup>I-conjugated/spermine-modified dextran polymer (<sup>125</sup>I-SD) by microfluidics for mesenchymal stem cell (MSC) tracking and activity maintenance. The CPMSN core not only exhibits excellent photoacoustic (PA) imaging performance induced by the intermolecular aggregation of CoPP within the mesopores but also protects the MSCs against oxidative stress by sustained release of CoPP. Meanwhile, the addition of a <sup>125</sup>I-SD shell can increase the uptake efficiency in MSCs without inducing cell variability and enable the single-photon-emission computed tomography (SPECT) nuclear imaging. <i>In vivo</i> results indicated that <sup>125</sup>I-SD labeling could allow for an optimal combination of instant imaging of MSCs, with PA to guide intracerebral injection, followed by multiple time point SPECT imaging to consecutively track the cell homing. Importantly, the sustained release of CoPP from <sup>125</sup>I-SD significantly increased the survival of MSCs after injection into an ischemic mouse brain and promoted neurobehavioral recovery in ischemic mice. Thus, <sup>125</sup>I-SD represents a robust theranostic probe for both MSC tracking and maintaining their therapeutic effect in the treatment of brain ischemia.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c10500?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c10500</a>.Characterization methods of cell differentiation, material degradation, bioluminescence imaging, neurobehavioral recovery, brain atrophy volume, and immunohistochemistry; pore structure; drug loading; polymer structure; molecular weight distribution; morphology control of a nanoprobe; SEM image; labeling stability of <sup>125</sup>I in a nanoprobe; XPS analysis; material cytotoxicity; release kinetic of the Si element; CoPP release; US/PA image of free CoPP; PA intensities of free CoPP and nanoprobe; PA intensity of labeled BMSCs in mouse brain; western blotting image of HO-1; mNSS; Rotarod test; and VEGF expression (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c10500/suppl_file/am0c10500_si_001.pdf">PDF</a>)<i>In vivo</i> PA imaging (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c10500/suppl_file/am0c10500_si_002.mp4">MP4</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology